Evidence map›Paper›PMID 30658015›Full record

ReviewAdvanced healthcare materials2019

Macrophage and Fibroblast Interactions in Biomaterial-Mediated Fibrosis.

Claire E Witherel, Daniel Abebayehu, Thomas H Barker, Kara L Spiller

Open access · greenAbstract readReview
In one paragraph

Review in Advanced healthcare materials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 188 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed, 1 pooled it
25.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 1 synthesis or guideline pooled it, 362 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Tissue-bioelectronics interfaces.Chemical Society reviews · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Claire E WitherelSchool of Biomedical Engineering, Science and Health Systems, Drexel University, 3141 Chestnut Street, Philadelphia, PA, 19104, USA.
Daniel AbebayehuDepartment of Biomedical Engineering, School of Engineering & School of Medicine, University of Virginia, 415 Lane Road, Charlottesville, VA, 22904, USA.
Thomas H BarkerDepartment of Biomedical Engineering, School of Engineering & School of Medicine, University of Virginia, 415 Lane Road, Charlottesville, VA, 22904, USA.
Kara L SpillerSchool of Biomedical Engineering, Science and Health Systems, Drexel University, 3141 Chestnut Street, Philadelphia, PA, 19104, USA.ORCID 0000-0001-7798-1490
Drexel University · USUniversity of Virginia · US

Funding

BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
Understanding and Controlling Macrophage Behavior in AngiogenesisR01HL130037 · NHLBI · DREXEL UNIVERSITY · PI SPILLER, KARA LORRAINE · 2016 to 2024
$4.7M
Mechanosensors that detect and treat Lung FibrosisR01HL132585 · NHLBI · UNIVERSITY OF VIRGINIA · PI BARKER, THOMAS HARRISON · 2015 to 2019
$3.3M
Targeting the alpha v integrin mechanotransduction axis in IPFR01HL127283 · NHLBI · UNIVERSITY OF VIRGINIA · PI BARKER, THOMAS HARRISON · 2015 to 2018
$1.6M
NHLBI NIH HHS R01 HL127283NHLBI NIH HHS R01 HL130037NHLBI NIH HHS R01 HL132585NHLBI NIH HHS T32 HL007284
6 · The paper itself

Abstract

Biomaterial-mediated inflammation and fibrosis remain a prominent challenge in designing materials to support tissue repair and regeneration. Despite the many biomaterial technologies that have been designed to evade or suppress inflammation (i.e., delivery of anti-inflammatory drugs, hydrophobic coatings, etc.), many materials are still subject to a foreign body response, resulting in encapsulation of dense, scar-like extracellular matrix. The primary cells involved in biomaterial-mediated fibrosis are macrophages, which modulate inflammation, and fibroblasts, which primarily lay down new extracellular matrix. While macrophages and fibroblasts are implicated in driving biomaterial-mediated fibrosis, the signaling pathways and spatiotemporal crosstalk between these cell types remain loosely defined. In this review, the role of M1 and M2 macrophages (and soluble cues) involved in the fibrous encapsulation of biomaterials in vivo is investigated, with additional focus on fibroblast and macrophage crosstalk in vitro along with in vitro models to study the foreign body response. Lastly, several strategies that have been used to specifically modulate macrophage and fibroblast behavior in vitro and in vivo to control biomaterial-mediated fibrosis are highlighted.

Indexed as

Biocompatible MaterialsExtracellular MatrixFibroblastsMacrophagesAnimalsAnti-Inflammatory AgentsFibrosisHumansAnti-Inflammatory AgentsBiocompatible Materialsbiomaterialsfibroblastsfibrosisforeign body responsemacrophages

Identifiers

PMID30658015
PMCPMC6415913
OpenAlexW2910745688

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.